A: The Commission's independence rules apply to audits of financial statements required by SEC rules, except for those required by Rule 3-05 and 3-14 of Regulation S-X and Item 310(c) and (e) of Regulation S-B.
1 The Centers for Disease Control and Prevention (CDC) recommends 2 doses of quadrivalent meningococcal conjugate vaccine for adolescents 11 through 18 years of age.  The first dose should be given at 11 or 12 years of age, followed by a booster dose at age 16.
Vaccine Recommendations. Meningococcal vaccines protect against most types of meningitis, but they do not prevent all cases. Meningococcal conjugate vaccine is recommended for people 11 â 54 years of age, as well as certain high-risk children from ages nine months through ten years.Adolescents should receive the first dose at 11 or 12 years of age, with a booster at age 16 to 18 years.accine Recommendations. Meningococcal vaccines protect against most types of meningitis, but they do not prevent all cases. Meningococcal conjugate vaccine is recommended for people 11 â 54 years of age, as well as certain high-risk children from ages nine months through ten years.